2000
DOI: 10.1053/joms.2000.8755
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous leishmaniasis affecting the face: Report of a case

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
1
0
2

Year Published

2002
2002
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 3 publications
1
1
0
2
Order By: Relevance
“…In the present study the CL ulcer was diagnosed as single or multiple painless ulcer occur on exposed areas, with a characteristic erythematous raised border with an overlying crust and leaving a disfiguring scar. The same description was also reported by many authors [25,26,27].…”
Section: Discussionsupporting
confidence: 80%
“…In the present study the CL ulcer was diagnosed as single or multiple painless ulcer occur on exposed areas, with a characteristic erythematous raised border with an overlying crust and leaving a disfiguring scar. The same description was also reported by many authors [25,26,27].…”
Section: Discussionsupporting
confidence: 80%
“…However, on the basis of the cases published so far (2 ± 7), cutaneous leishmaniasis of the lips appears to be very rare outside Saudi Arabia. Furthermore, some cases described as leishmaniasis of the lips were actually examples of leishmaniasis of the face (4,6).…”
Section: Discussionmentioning
confidence: 99%
“…Entretanto existe certa dificuldade na realização do exame no Sistema Único de Saúde (SUS) devido ao seu alto custo 11,19 . Quanto ao tratamento, as drogas de primeira escolha na LTA são os Atimoniais Pentavalentes (Sb+5) 20 , e não havendo resposta satisfatória ou havendo contra indicações ao tratamento, as drogas de segunda escolha são a Anfotericina B e a Pentamidina 1 . No caso apresentado, após a confirmação diagnóstica pela biópsia, o caso foi conduzido por equipe médica em ambiente hospitalar, que optou por não realizar nenhum tratamento local, e neste caso, a forma Lipossomal da Anfotericina B foi o medicamento de escolha para o tratamento, por agir especificamente sobre células-alvo (macrófagos), incorporando ao meio intracelular e assim reduzindo efeitos colaterais 21 .…”
Section: Discussionunclassified